Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature

S Wolking, E Schaeffeler, H Lerche, M Schwab… - Clinical …, 2015 - Springer
ATP-binding cassette transporter B1 (ABCB1; P-glycoprotein; multidrug resistance protein 1)
is an adenosine triphosphate (ATP)-dependent efflux transporter located in the plasma …

Genetic polymorphisms and paclitaxel-or docetaxel-induced toxicities: a systematic review

CN Frederiks, SW Lam, HJ Guchelaar, E Boven - Cancer treatment reviews, 2015 - Elsevier
Background Taxanes, including paclitaxel and docetaxel, are indispensable for treatment of
cancer. Development of toxicity frequently necessitates dose reduction or discontinuation of …

Cytochrome P450 in cancer susceptibility and treatment

B Mittal, S Tulsyan, S Kumar, RD Mittal… - Advances in clinical …, 2015 - Elsevier
Abstract Cytochrome 450 (CYP450) designates a group of enzymes abundant in smooth
endoplasmic reticulum of hepatocytes and epithelial cells of small intestines. The main …

Toxicity and pharmacogenomic biomarkers in breast cancer chemotherapy

ZN Al-Mahayri, GP Patrinos, BR Ali - Frontiers in pharmacology, 2020 - frontiersin.org
Breast cancer (BC) is one of the most prevalent types of cancer worldwide with high
morbidity and mortality rates. Treatment modalities include systemic therapy, in which …

[HTML][HTML] Pharmacogenetics of toxicity of 5-fluorouracil, doxorubicin and cyclophosphamide chemotherapy in breast cancer patients

K Tecza, J Pamula-Pilat, J Lanuszewska… - Oncotarget, 2018 - ncbi.nlm.nih.gov
The differences in patients' response to the same medication, toxicity included, are one of
the major problems in breast cancer treatment. Chemotherapy toxicity makes a significant …

Acquisition of anticancer drug resistance is partially associated with cancer stemness in human colon cancer cells

F El Khoury, L Corcos, S Durand… - International …, 2016 - spandidos-publications.com
Colorectal cancer (CRC) is one of the most aggressive cancers worldwide. Several
anticancer agents are available to treat CRC, but eventually cancer relapse occurs. One …

The effect of ABCB1 polymorphisms on the outcome of breast cancer treatment

S Tulsyan, RD Mittal, B Mittal - … and personalized medicine, 2016 - Taylor & Francis
The ABCB1 gene encodes a permeability glycoprotein, which is one of the most extensively
studied human adenosine-triphosphate (ATP)-dependent efflux transporters. Permeability …

Influence of polymorphic OATP1B-type carriers on the disposition of docetaxel

AJM de Graan, CS Lancaster, A Obaidat… - Clinical Cancer …, 2012 - AACR
Purpose: Docetaxel is extensively metabolized by CYP3A4 in the liver but mechanisms by
which the drug is taken up into hepatocytes remain poorly understood. We hypothesized that …

[HTML][HTML] SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand

R Palmirotta, C Carella, E Silvestris, M Cives… - Oncotarget, 2018 - ncbi.nlm.nih.gov
In the “precision medicine” era, chemotherapy still remains the backbone for the treatment of
many cancers, but no affordable predictors of response to the chemodrugs are available in …

Pharmacogenetics of taxanes: impact of gene polymorphisms of drug transporters on pharmacokinetics and toxicity

RS Jabir, R Naidu, MABA Annuar, GF Ho… - …, 2012 - Taylor & Francis
Interindividual variability in drug response and the emergence of adverse drug effects are
the main causes of treatment failure in cancer therapy. Functional membrane drug …